Patents Assigned to Gemin X Biotechnologies Inc.
  • Publication number: 20080280896
    Abstract: The present invention relates to novel Dipyrrole Compounds, compositions comprising a Dipyrrole Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a Dipyrrole Compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell, treating or preventing a viral infection, or inhibiting the replication and/or infectivity of a virus. The invention also provides screening assays for compounds that can be used in combination with Dipyrrole Compounds for the treatment of cancer or neoplastic disease, inhibition of cancer cell growth, or treatment of viral infections.
    Type: Application
    Filed: December 22, 2005
    Publication date: November 13, 2008
    Applicant: GEMIN X BIOTECHNOLOGIES INC.
    Inventors: Giorgio Attardo, Sasmita Triparthy, Elise Rioux, Gerson Gonzalez
  • Publication number: 20080076739
    Abstract: The present invention relates to methods for treating or preventing arthritis comprising administering a Triheterocyclic Compound. In one embodiment, the present invention relates to methods of using Triheterocyclic Compounds for treating or preventing rheumatoid arthritis comprising administering a Triheterocyclic Compound.
    Type: Application
    Filed: August 22, 2007
    Publication date: March 27, 2008
    Applicant: Gemin X Biotechnologies Inc.
    Inventor: Jean Viallet
  • Publication number: 20080051400
    Abstract: The present invention relates to methods useful for treating or preventing anemia or thrombocytopenia, comprising administrating an effective amount of a Triheterocyclic Compound to a subject in need thereof. The present invention also relates to methods useful for preventing anemia or thrombocytopenia in a subject, comprising administrating an effective amount of a Triheterocyclic Compound to the subject, wherein the subject is at heightened risk of developing anemia or thrombocytopenia.
    Type: Application
    Filed: July 5, 2007
    Publication date: February 28, 2008
    Applicant: Gemin X Biotechnologies Inc.
    Inventors: Jean Viallet, Susan O'Brien
  • Publication number: 20070037856
    Abstract: The present invention relates to novel Pyrrole-Type compounds, compositions comprising Pyrrole-Type compounds, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a composition comprising a Pyrrole-Type compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing a viral infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the replication and/or infectivity of a virus.
    Type: Application
    Filed: October 16, 2006
    Publication date: February 15, 2007
    Applicant: Gemin X Biotechnologies Inc.
    Inventors: Roy Johnson, Giorgio Attardo
  • Patent number: 7144912
    Abstract: The present invention relates to novel Pyrrole-Type compounds, compositions comprising Pyrrole-Type compounds, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a Pyrrole-Type compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing a viral infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the replication and/or infectivity of a virus. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for causing immunosuppression. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing an autoimmune disease.
    Type: Grant
    Filed: July 18, 2002
    Date of Patent: December 5, 2006
    Assignee: Gemin X Biotechnologies Inc.
    Inventors: Roy A. Johnson, Giorgio Attardo
  • Publication number: 20040014987
    Abstract: The present invention relates to novel Pyrrole-Type compounds, compositions comprising Pyrrole-Type compounds, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a composition comprising a Pyrrole-Type compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing a viral infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the replication and/or infectivity of a virus.
    Type: Application
    Filed: March 19, 2003
    Publication date: January 22, 2004
    Applicant: Gemin X Biotechnologies Inc.
    Inventors: Madiraju S.R. Murthy, Nancy A.E. Steenaart, Roy A. Johnson, Gordon C. Shore
  • Patent number: 6602879
    Abstract: The present invention relates to novel Pyrrole-Type compounds, compositions comprising Pyrrole-Type compounds, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a composition comprising a Pyrrole-Type compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing a viral infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the replication and/or infectivity of a virus.
    Type: Grant
    Filed: April 4, 2002
    Date of Patent: August 5, 2003
    Assignee: Gemin X Biotechnologies Inc.
    Inventors: Madiraju S. R. Murthy, Nancy A. E. Steenaart, Roy A. Johnson, Gordon C. Shore
  • Publication number: 20030119894
    Abstract: The present invention provides methods for treating or preventing cancer or neoplastic disease comprising administering to a patient a compound having the features of a pharmacophore for human anti-apotptotic Bcl protein inhibitors or identified by the in vitro methods for identifying anti-apotptotic-Bcl protein inhibitors. Also disclosed are methods for inhibiting the growth of a cancer cell or a neoplastic cell, comprising contacting the cancer cell or neoplastic cell with a compound having the features of a pharmacophore for human anti-apoptotic-Bcl protein inhibitors.
    Type: Application
    Filed: July 20, 2001
    Publication date: June 26, 2003
    Applicant: Gemin X Biotechnologies Inc.
    Inventors: Madiraju S.R. Murthy, Gordon C. Shore, Jurgen Bajorath, Florence L. Stahura
  • Patent number: 6407244
    Abstract: The present invention relates to novel Pyrrole-Type compounds, compositions comprising Pyrrole-Type compounds, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a composition comprising a Pyrrole-Type compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell. The present invention also relates to novel Pyrrole-Type compounds, compositions, and methods useful for treating or preventing a viral infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the replication and/or infectivity of a virus.
    Type: Grant
    Filed: January 26, 2000
    Date of Patent: June 18, 2002
    Assignee: Gemin X Biotechnologies Inc.
    Inventors: Madiraju S. R. Murthy, Nancy A. E. Steenaart, Roy A. Johnson, Gordon C. Shore